Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Regulatory News (ETX)

  • There is currently no data for ETX

Director Declaration

9 Jun 2009 11:36

RNS Number : 5979T
e-Therapeutics plc
09 June 2009
Β 

ο»Ώ

e-Therapeutics plc

('ETX' or 'the Company')

CHANGE TO DIRECTOR'S DETAILS

Β 

Pursuant to Rule 17 and Schedule 2 paragraph (g) of the AIM Rules for Companies,Β Dr Royston Drucker (Chief Medical Officer of the Company)Β has become aware thatΒ Β Technomark Consulting ServicesΒ Limited, a company of whichΒ heΒ was a non-executive director until his resignation on 08 June 2007, entered a company voluntary arrangement on 17 March 2008.Β 

Dr Royston Drucker has no further details at this time.

Β 

For further information please contact:

e-Therapeutics plc

www.etherapeutics.co.uk

Malcolm Young

+44 (0) 191 233 1317

Nominated Adviser

WH Ireland Limited

+44 (0) 161 832 2174

Katy Mitchell

Broker

Cornhill Asset Management

+44 (0) 207 645 8327

Tom Whitehead

Media enquiries

Abchurch

Heather Salmond

+44 (0) 207 398 7704

Stephanie Cuthbert

+44 (0) 207 398 7718

Simone Alves

+44 (0) 207 398 7728

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDNUUUPWQUPBGUB
Date   Source Headline
31st May 20182:13 pmRNSResults of Annual General Meeting
1st May 20187:00 amRNSCollaboration with C4X Discovery Holdings PLC
4th Apr 20184:13 pmRNSNotice of AGM
27th Mar 20187:00 amRNSFull Year Results
12th Mar 20187:00 amRNSNotification of Full Year Results Date
22nd Jan 20187:00 amRNSDirector/PDMR Shareholding
15th Jan 20187:00 amRNSE-Therapeutics enters two AI collaborations
3rd Jan 20187:00 amRNSDirector/PDMR Shareholding
18th Dec 20172:31 pmRNSHolding(s) in Company
18th Dec 20178:57 amRNSDirector/PDMR Shareholding
1st Nov 20177:00 amRNSAppointment of Director
5th Oct 201711:35 amEQSEdison issues update on e-Therapeutics (ETX)
26th Sep 20177:00 amRNSInterim Results for 6 Months Ended 31 July 2017
5th Sep 20179:41 amRNSNotice of Results
22nd Aug 20172:13 pmRNSDirector/PDMR Shareholding
27th Jul 20174:46 pmRNSEdison issues update on e-Therapeutics (ETX)
27th Jul 20173:24 pmEQSEdison Investment Research Limited: Edison issues update on e-Therapeutics (ETX)
24th Jul 20177:00 amRNSOutcome of Strategic Review and Future Plans
3rd Jul 20174:50 pmRNSDirector/PDMR Shareholding
19th Jun 201710:13 amRNSTR-1: Notification of Major Interest in Shares
5th Jun 20172:21 pmRNSTR-1: Notification of Major Interest in Shares
2nd Jun 20173:19 pmRNSTR-1: Notification of Major Interest in Shares
2nd Jun 20172:50 pmRNSTR-1: Notification of Major Interest in Shares
2nd Jun 201712:02 pmRNSTR-1: Notification of Major Interest in Shares
2nd Jun 20179:00 amRNSDirector/PDMR Shareholding
31st May 20172:01 pmRNSResults of Annual General Meeting
25th May 201711:20 amRNSNotification by Director
23rd May 20174:22 pmRNSDirector/PDMR Shareholding
8th May 20173:02 pmRNSNotice of Annual General Meeting and Annual Report
3rd May 20179:00 amRNSDirector/PDMR Shareholding
19th Apr 20177:00 amRNSFinal Results
6th Apr 20177:01 amRNSNotification of Full Year Results Date
6th Apr 20177:00 amRNSNew CEO Commences at e-Therapeutics
4th Apr 20178:30 amRNSHolding(s) in Company
4th Apr 20178:30 amRNSHolding(s) in Company
16th Feb 20177:00 amRNSDirectorate Change
12th Jan 201710:38 amRNSHolding(s) in Company
9th Jan 20177:00 amRNSAppointment of CEO
4th Jan 20177:00 amRNSDirector/PDMR Shareholding
23rd Nov 20164:21 pmRNSGrant of share options and Directors' dealings
6th Oct 201610:12 amRNSDirectors' Dealings and Issue of Equity
3rd Oct 20162:03 pmRNSFurther re: Directors' Shareholdings
21st Sep 20164:06 pmRNSIssue of Equity and Directors' shareholdings
20th Sep 20167:00 amRNSHalf year results
14th Sep 201612:08 pmRNSManagement Update
9th Sep 20169:30 amRNSNotice of Half Year Results
18th Aug 20165:07 pmRNSHolding(s) in Company - Correction
18th Aug 201611:07 amRNSHolding(s) in Company
1st Aug 20164:40 pmRNSIssue of Equity
13th Jul 201610:05 amRNSBoard changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.